Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Pruritus, Rash macular, Urticaria
Clinical narrative: Skin was itchy especially his face and by the third night he had blotchy red patches on face (not normal for him), by the fourth night the blotch patches had become hives, itchy.; Skin was itchy especially his face and by the third night he had blotchy red patches on face (not normal for him), by the fourth night the blotch patches had become hives, itchy.; After 2nd vaccination patient had swollen lymph glands under left arm (where he received shot) and it lasted about a week. He still feel tender under arm but bearable.; After 2nd vaccination patient had swollen lymph glands under left arm (where he received shot) and it lasted about a week. He still feel tender under arm but bearable.; Skin was itchy especially his face and by the third night he had blotchy red patches on face (not normal for him), by the fourth night the blotch patches had become hives, itchy.; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWD171) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C), calcium pantothenate/ nicotinamide/ pyridoxine hydrochloride/ riboflavin sodium phosphate/ thiamine hydrochloride (VITAMIN B COMPLEX) and tagetes spp. (LUTEIN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 22Mar2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, second day after 2nd vaccination the patient woke up with swollen lymph glands under the left arm (where the shot was received). It lasted about a week. The patient still felt tender under arm but bearable. On an unknown date in Apr2021, the patient felt skin was itchy especially on the face and this was more concerning for the first few days after 2nd dose. On 21Apr2021, by the third night the patient had blotchy red patches on the face (not normal for the patient) and on 22Apr2021, by the fourth night the blotch patches had become hives, itchy.  The patient left it alone for a couple of days to see if it would go away, it subsided but would randomly flare up and would have hives again. The patient rubbed over the counter (OTC) cortizone cream on them and it cleared them up. However, the week of reporting the itchy, blotch skin was back and the patient was still getting slightly raised hives on the face, nowhere else on the body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken for the events skin was itchy, blotchy red patches on the face, hives, itchy and included treatment with over the counter (OTC) hydrocortisone (CORTIZONE) cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph glands under left arm, tender under arm, skin was itchy especially the face, blotchy red patches on face, blotch patches had become hives, itchy were recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.